Hearing loss

Hearing Aid Specialist Tops 2024 Job List

Retrieved on: 
Thursday, January 18, 2024

FARMINGTON, Mich., Jan. 18, 2024 /PRNewswire/ -- For the second year in a row, the U.S. News & World Report (USNWR) January 9 edition ranked Hearing Aid Specialist as a best job for 2024.

Key Points: 
  • FARMINGTON, Mich., Jan. 18, 2024 /PRNewswire/ -- For the second year in a row, the U.S. News & World Report (USNWR) January 9 edition ranked Hearing Aid Specialist as a best job for 2024.
  • Hearing Aid Specialist moved up on many of the magazine's 2024 rankings, including taking the top spot on their list of Best Jobs Without A College Degree, and moving up fifty points to 32nd on their 100 Best Jobs list.
  • Hearing Aid Specialist tops US 2024 Job List, coming in at #1 on Best Jobs Without a College Degree!
  • Executive Director of International Hearing Society Alissa Parady said, "The opportunities are vast for individuals considering a new career as a hearing aid specialist.

HearUSA Furthers Goal of Expanding Access to Simply Excellent Hearing Care with Planned Opening of 17 New Hearing Centers of the Future in 2024

Retrieved on: 
Wednesday, January 17, 2024

PALM BEACH GARDENS, Fla., Jan. 17, 2024 /PRNewswire/ -- Leading hearing care retailer HearUSA today accelerated its mission of expanding access to Simply Excellent Hearing Care in 2024 with the announcement of 17 planned Hearing Center of the Future openings in California, Florida, Michigan, and Texas. The new centers are an addition to the eight centers that opened in 2023, all with the goal of bringing an entirely new, client-centric hearing care experience to more Americans than ever before.

Key Points: 
  • PALM BEACH GARDENS, Fla., Jan. 17, 2024 /PRNewswire/ -- Leading hearing care retailer HearUSA today accelerated its mission of expanding access to Simply Excellent Hearing Care in 2024 with the announcement of 17 planned Hearing Center of the Future openings in California, Florida, Michigan, and Texas.
  • "In 2024, we are taking the next step forward with our planned openings of 17 new centers over the next 12 months, significantly expanding access to Simply Excellent Hearing Care."
  • All HearUSA Hearing Centers of the Future are designed from the ground up to make accessing hearing care easier and more client-centric than ever before.
  • HearUSA's commitment to improving hearing care access goes beyond simply opening new hearing centers.

Dr. Raymond Douglas Publishes Prospective Study in Thyroid Medical Journal Examining Audiometry Outcomes Following Tepezza for Thyroid Eye Disease

Retrieved on: 
Tuesday, January 16, 2024

BEVERLY HILLS, Calif., Jan. 16, 2024 /PRNewswire-PRWeb/ -- Raymond Douglas MD, PhD led a new study finding long term hearing loss is rare in those with normal audiometry at baseline following treatment with Tepezza [teprotumumab]. The results also showed with predictability that patients with preexisting hearing issues were those who would potentially develop loss. The study was just published for the current issue of the prestigious journal Thyroid, the definitive peer-reviewed medical journal in thyroid disease, care, and research, providing multidisciplinary original and patient-focused reports.

Key Points: 
  • BEVERLY HILLS, Calif., Jan. 16, 2024 /PRNewswire-PRWeb/ -- Raymond Douglas MD, PhD led a new study finding long term hearing loss is rare in those with normal audiometry at baseline following treatment with Tepezza [teprotumumab].
  • The results also showed with predictability that patients with preexisting hearing issues were those who would potentially develop loss.
  • The study was just published for the current issue of the prestigious journal Thyroid , the definitive peer-reviewed medical journal in thyroid disease, care, and research, providing multidisciplinary original and patient-focused reports.
  • "Our study conclusively confirmed that hearing loss with Tepezza treatment is in fact very rare", said Dr. Raymond Douglas, lead investigator and author.

Thin-film Batteries Market to increase by USD 2.58 billion between 2022 to 2027; The proliferation of IoT devices has driven the demand for thin-film batteries- Technavio

Retrieved on: 
Tuesday, January 16, 2024

NEW YORK, Jan. 15, 2024 /PRNewswire/ -- The thin-film batteries market size is expected to grow by USD 2.58 billion from 2022 to 2027, according to Technavio.

Key Points: 
  • NEW YORK, Jan. 15, 2024 /PRNewswire/ -- The thin-film batteries market size is expected to grow by USD 2.58 billion from 2022 to 2027, according to Technavio.
  • The global off-grid thin-film batteries market is expected to grow rapidly during the forecast period due to the Increasing occurrences of hearing loss.
  • The light vehicle batteries market size is expected to increase by USD 34.06 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 12.72%.
  • The Marine Powerboats Batteries Market size is estimated to grow at a CAGR of 8.6% between 2023 and 2027.

CHS Global Partnerships for Research & Innovation Awards Four Research Grants to Institutions Leading Research to Improve the Quality of Life for Deaf and Hard of Hearing Individuals

Retrieved on: 
Wednesday, January 10, 2024

TORONTO, Jan. 10, 2024 (GLOBE NEWSWIRE) -- CHS Global Partnerships for Research & Innovation, a non-profit organization and strategic global leader in the advancement of research and innovation that improves the quality of life for Deaf and hard of hearing individuals, is excited to announce that it has awarded four additional research grants to institutions leading research that will break down barriers to participation for Deaf and hard of hearing individuals and their families. Since its launch in January 2022, CHS Global Partnerships for Research & Innovations has proudly awarded a total of $782,425 in research grants.

Key Points: 
  • Since its launch in January 2022, CHS Global Partnerships for Research & Innovations has proudly awarded a total of $782,425 in research grants.
  • Each of the winning research projects has the potential to unlock new insights and breakthroughs in the field of hearing health and Deaf studies.
  • By supporting cutting-edge research, CHS Global Partnerships for Research & Innovation, aims to contribute not only to the global scientific community but, most importantly, to deliver on our mission of improving the lives of Deaf and hard of hearing individuals.
  • Results from this research will define a novel way to improve hearing for children using cochlear implants.

Smart Wearables Leader Zepp Health Unveils the Amazfit Helio Ring for Optimum Athletic Performance at CES 2024

Retrieved on: 
Tuesday, January 9, 2024

CES — Zepp Health Corporation ("Zepp Health") (NYSE: ZEPP), a global leader in smart wearables and health technology, today revealed key evolutions in its smart wearable portfolio at Pepcom's Digital Experience at CES.

Key Points: 
  • CES — Zepp Health Corporation ("Zepp Health") (NYSE: ZEPP), a global leader in smart wearables and health technology, today revealed key evolutions in its smart wearable portfolio at Pepcom's Digital Experience at CES.
  • View the full release here: https://www.businesswire.com/news/home/20240109707015/en/
    Unlocking Peak Performance: The Amazfit Helio Ring redefines athletic recovery with advanced monitoring, analysis, and guidance for athletes pursuing ultimate performance.
  • The Amazfit Helio Ring and Zepp Clarity Pixie exemplify our commitment to providing accessible, intelligent healthcare solutions that enhance their lives," said Wayne Huang, CEO of Zepp Health.
  • The Amazfit Helio Ring will be available in early Spring 2024 on the official Amazfit website , where you can now sign up for updates about the Amazfit Helio Ring.

Nagish, which empowers accessible communication through AI, has been certified by the FCC to provide relay services

Retrieved on: 
Wednesday, January 10, 2024

NEW YORK, Jan. 10, 2024 /PRNewswire/ -- Nagish, which uses AI to make communication accessible for deaf and hard of hearing individuals, has been certified by the Federal Communications Commission (FCC) to provide telecommunication relay services.

Key Points: 
  • NEW YORK, Jan. 10, 2024 /PRNewswire/ -- Nagish, which uses AI to make communication accessible for deaf and hard of hearing individuals, has been certified by the Federal Communications Commission (FCC) to provide telecommunication relay services.
  • The certification makes Nagish one of the very few certified providers, accelerating the company's growth and advancement of accessibility.
  • The recognition solidifies Nagish as a pioneer in the field, setting new standards for accessibility and ease of use in relay services.
  • The FCC Telecommunication Relay Services (TRS) fund reimburses certified relay providers who provide accessible communication solutions.

Acousia Therapeutics attracts new investor on its path to make hearing loss a treatable disease

Retrieved on: 
Tuesday, January 9, 2024

The infusion of fresh capital is set to boost the progress of Acousia's Kv7.4 activator programs, with a focus on advancing the ongoing clinical development of ACOU085.

Key Points: 
  • The infusion of fresh capital is set to boost the progress of Acousia's Kv7.4 activator programs, with a focus on advancing the ongoing clinical development of ACOU085.
  • ACOU085 is a proprietary, small-molecule, etiology-agnostic otoprotective drug candidate, which recently entered Phase 2 clinical testing for the prevention of chemotherapy-induced hearing loss and sensory hair cell death in cancer patients.
  • The significant otoprotective potential of ACOU085 is broadly supported by results from a number of preclinical studies in relevant models.
  • Our lead candidate ACOU085, currently in Clinical Phase 2, aims to set a new standard for treating acute and subacute forms of hearing loss."

Acousia Therapeutics attracts new investor on its path to make hearing loss a treatable disease

Retrieved on: 
Tuesday, January 9, 2024

The infusion of fresh capital is set to boost the progress of Acousia's Kv7.4 activator programs, with a focus on advancing the ongoing clinical development of ACOU085.

Key Points: 
  • The infusion of fresh capital is set to boost the progress of Acousia's Kv7.4 activator programs, with a focus on advancing the ongoing clinical development of ACOU085.
  • ACOU085 is a proprietary, small-molecule, etiology-agnostic otoprotective drug candidate, which recently entered Phase 2 clinical testing for the prevention of chemotherapy-induced hearing loss and sensory hair cell death in cancer patients.
  • The significant otoprotective potential of ACOU085 is broadly supported by results from a number of preclinical studies in relevant models.
  • Our lead candidate ACOU085, currently in Clinical Phase 2, aims to set a new standard for treating acute and subacute forms of hearing loss."

RCA Accessories To Expand its Presence in the Multi-Billion-Dollar Over-the-Counter Hearing Aid Market with the Launch of Three New Premium RCA Models

Retrieved on: 
Monday, January 8, 2024

Ian Geise, President of VOXX Accessories Corporation stated, "We have made significant enhancements to our product offering and are very excited about the upcoming RCA hearing aid and protection plan launches.

Key Points: 
  • Ian Geise, President of VOXX Accessories Corporation stated, "We have made significant enhancements to our product offering and are very excited about the upcoming RCA hearing aid and protection plan launches.
  • Now, RCA will unveil three new models that provide enhanced capabilities, use and comfort to a wider demographic in need.
  • Believed to be the world's first OTC hearing aid with a wireless remote to control volume, this consumer friendly hearing aid is comfortable and easy to use and IP22 water resistant.
  • All RCA OTC hearing aids meet all FDA requirements and are FDA compliant.